Glass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMill’s Director Candidates and Proposals

WaterMill Asset Management Corp. (together with its affiliates, "WaterMill" or "we") today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading proxy advisory firm, has endorsed its case for meaningful change at Ziopharm Oncology, Inc...
Login to comment.